At 30, Brendan sought thrills like skydiving and ice climbing. Battling stage 4 metastatic melanoma, he underwent surgeries and participated in immunotherapy trials. He’s now cancer free and excited to share why you should participate in #Immune2Cancer Day.
Brendan’s #Immune2Cancer Message
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
